CR10508A - Nuevo determinante de virulencia dentro de la glicoproteina estructural e2 del virus de la peste porcina clasica - Google Patents

Nuevo determinante de virulencia dentro de la glicoproteina estructural e2 del virus de la peste porcina clasica

Info

Publication number
CR10508A
CR10508A CR10508A CR10508A CR10508A CR 10508 A CR10508 A CR 10508A CR 10508 A CR10508 A CR 10508A CR 10508 A CR10508 A CR 10508A CR 10508 A CR10508 A CR 10508A
Authority
CR
Costa Rica
Prior art keywords
glycroprotein
structural
classical swine
swine virus
virulence determinant
Prior art date
Application number
CR10508A
Other languages
English (en)
Inventor
Manuel V Borca
Guillermo R Risatti
Original Assignee
Secretaria De Agricultura De Los Estados Unidos De Amera
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secretaria De Agricultura De Los Estados Unidos De Amera filed Critical Secretaria De Agricultura De Los Estados Unidos De Amera
Publication of CR10508A publication Critical patent/CR10508A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CR10508A 2006-05-30 2008-12-15 Nuevo determinante de virulencia dentro de la glicoproteina estructural e2 del virus de la peste porcina clasica CR10508A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/443,132 US8846055B2 (en) 2006-05-30 2006-05-30 Virulence determinant within the E2 structural glycoprotein of classical swine fever virus

Publications (1)

Publication Number Publication Date
CR10508A true CR10508A (es) 2009-02-23

Family

ID=38790491

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10508A CR10508A (es) 2006-05-30 2008-12-15 Nuevo determinante de virulencia dentro de la glicoproteina estructural e2 del virus de la peste porcina clasica

Country Status (14)

Country Link
US (1) US8846055B2 (es)
EP (1) EP2023953B1 (es)
JP (1) JP5377296B2 (es)
KR (1) KR101432840B1 (es)
CN (1) CN101478985B (es)
BR (1) BRPI0712558A2 (es)
CA (1) CA2656560A1 (es)
CR (1) CR10508A (es)
GT (1) GT200800269A (es)
MX (1) MX2008015215A (es)
RU (1) RU2451746C2 (es)
UA (1) UA98620C2 (es)
WO (1) WO2007143442A2 (es)
ZA (1) ZA200810285B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114852B2 (en) * 2008-01-15 2012-02-14 The United States Of America As Represented By The Secretary Of Agriculture N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
US20100104597A1 (en) * 2008-10-24 2010-04-29 Manuel Borca N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
EP2202298A1 (en) * 2008-12-23 2010-06-30 Stichting Dienst Landbouwkundig Onderzoek Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV
KR101845571B1 (ko) * 2010-05-18 2018-04-04 림사 파르마 게엠베하 전통적 돼지열에 대한 마커 백신
CN102175849B (zh) * 2010-12-22 2013-07-03 江苏出入境检验检疫局动植物与食品检测中心 一种快速检测猪瘟抗体的试剂盒及其制备方法
CN102268079B (zh) * 2011-05-03 2013-04-03 新乡学院 猪瘟病毒csfv e2蛋白配体表位多肽及其应用
CN103499693A (zh) * 2013-10-11 2014-01-08 重庆出入境检验检疫局检验检疫技术中心 猪瘟病毒抗体竞争AlphaLISA检测试剂盒及检测方法
JP6383422B2 (ja) 2013-12-19 2018-08-29 インターベット インターナショナル ベー． フェー． Ｃｓｆｖ抗体に関する改善された診断試験
EP3146042B1 (en) 2014-05-23 2019-07-10 Boehringer Ingelheim Vetmedica GmbH Recombinant classical swine fever virus (csfv) comprising substitution in the tav epitope of the e2 protein
CN104483490B (zh) * 2014-12-09 2016-06-08 武汉科前生物股份有限公司 一种猪瘟病毒阻断elisa抗体检测试剂盒及应用
US9814771B2 (en) * 2015-09-11 2017-11-14 The United States Of America, As Represented By The Secretary Of Agriculture Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2
WO2017195919A1 (ko) * 2016-05-12 2017-11-16 주식회사 바이오앱 식물 유래의 돼지 열병 백신용 조성물 및 이의 제조방법
US9808520B1 (en) * 2016-07-01 2017-11-07 The United States Of America As Represented By The Secretary Of Agriculture Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate
CN106749519B (zh) * 2016-11-15 2020-04-07 河南省农业科学院 基于计算机模拟的csfv e2蛋白靶向结合的肽配基序列设计及应用
CN109324193A (zh) * 2018-12-07 2019-02-12 中国农业科学院兰州兽医研究所 一种猪瘟病毒抗体的可视化快速检测试剂盒及其应用
CN112961224B (zh) * 2021-03-26 2022-09-27 中国农业大学 牛病毒性腹泻病毒1型病毒样颗粒的制备及应用
EP4105225A1 (en) * 2021-06-18 2022-12-21 Institut de Recerca i Tecnologia Agroalimentàries Peptide-based assay to differentiate animals infected with csfv from vaccinated animals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0982402A1 (en) * 1998-08-14 2000-03-01 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Pestivirus vaccination

Also Published As

Publication number Publication date
CN101478985B (zh) 2013-10-30
KR101432840B1 (ko) 2014-09-22
JP5377296B2 (ja) 2013-12-25
CN101478985A (zh) 2009-07-08
GT200800269A (es) 2009-05-04
UA98620C2 (uk) 2012-06-11
WO2007143442A3 (en) 2008-03-13
KR20090025291A (ko) 2009-03-10
WO2007143442A2 (en) 2007-12-13
US20070280955A1 (en) 2007-12-06
EP2023953B1 (en) 2014-11-19
EP2023953A2 (en) 2009-02-18
RU2008150400A (ru) 2010-07-10
EP2023953A4 (en) 2010-01-20
ZA200810285B (en) 2010-07-28
MX2008015215A (es) 2009-02-06
US8846055B2 (en) 2014-09-30
JP2009538628A (ja) 2009-11-12
BRPI0712558A2 (pt) 2012-11-20
RU2451746C2 (ru) 2012-05-27
CA2656560A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
CR10508A (es) Nuevo determinante de virulencia dentro de la glicoproteina estructural e2 del virus de la peste porcina clasica
LTPA2017019I1 (lt) Žmogaus antikūnai, pasižymintys dideliu giminingumu PCSK9
BRPI0814003A2 (pt) Formulações de anticorpo
BRPI0814252A2 (pt) Formulações de anticorpo
FR2896407B3 (fr) Ambulateur
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
BRPI0821402A2 (pt) Frasco de perfume
BRPI0920428A2 (pt) inalador.
BRPI0819073A2 (pt) fralda descartável
BRPI0815440A2 (pt) 5-substituidos 2- (alcoximetil) furanos
BRPI0917567A2 (pt) tratamento de doença respiratória
BRPI0808246A2 (pt) "fralda descartável".
BRPI0907268A2 (pt) "seringa de segurança"
BRPI0819071A2 (pt) fralda descartável
DE112008003934A5 (de) Kosmetikmaske
BRPI0921947A2 (pt) formulações de proteína terapêutica
DK2131818T3 (da) Ny doseringsform
BRPI0807804A2 (pt) " arilciclopentenos substituídos como agentes terapêuticos ".
FR2905241B1 (fr) Dose echantillon avec applicateur
BRPI0822637A2 (pt) Uso de lanosta-8, 24-dien-3-óis
BRPI0916092A2 (pt) "isoformas específicas de anticorpos anti-her4"
BRPI0907797A2 (pt) Novo uso de 3,3'-diindolimetano
BRPI0815055A2 (pt) aparelho de ciclone.
BRPI1009814A2 (pt) Uso de estigmasterol, e, composição.
BRPI0811431A2 (pt) Composição farmacêutica aquosa.